RxDoctor Payments Data

Emily Davidson, MD

Urogynecology and Reconstructive Pelvic Surgery · Milwaukee, WINPI 1750644415

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (59.5%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Medtronic at 58.0% of the total.

$4,435in general payments, 2019–2025

Across 40 payments — averaging $110.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$3K
  • Boston Scientific$1K
  • Caldera Medical, Inc$365
  • Axonics, Inc.$297
  • Coloplast$80
  • Vertex$75
  • plus $32 from 1 others
$1,260in research payments, 2019–2025

Across 3 payments — averaging $420.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$1K

What the payments were for

  • Consulting fees$1,10325%
  • Travel & lodging$69416%
  • Food & beverage$2,63959%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,435 in reported general payments places this provider in the 55th percentile of 25 urogynecology and reconstructive pelvic surgery providers in Wisconsin.

See all urogynecology and reconstructive pelvic surgery providers in Wisconsin

Medicare billing

Part B allowed, 2024
$57,902
Medicare patients
193
Services billed
499

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron367$316,705
GemtesaVibegron284$224,440
ElmironPentosan Polysulfate Sodium20$32,336
Estradiol306$21,069
EstringEstradiol25$13,018
PremarinEstrogens, Conjugated24$10,212
Mirabegron ErMirabegron18$5,641
Trospium Chloride ErTrospium Chloride16$3,448
Fosfomycin Tromethamine12$1,367
Trimethoprim15$1,131
Clobetasol Propionate17$736
Solifenacin Succinate19$644
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst35$639
Oxybutynin Chloride ErOxybutynin Chloride24$418
Cephalexin28$410

Paid to pharmacies, not to this prescriber.

Other urogynecology and reconstructive pelvic surgery in Milwaukee

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →